Search companies or stocks...
The financial statements for BMEA (BMEA) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
| UNCY Unicycive Therapeutics, Inc. | $7.38 +5.13% |
| ALXO ALX Oncology Holdings Inc. | $1.90 +0.53% |
| CAMP CAMP4 Therapeutics Corporation | $4.39 -2.23% |
| M Macy's, Inc. | $21.76 -3.07% |
| E Eni S.p.A. | $52.16 -0.29% |
| PMVP PMV Pharmaceuticals, Inc. | $1.20 +0.84% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| UNCY Unicycive Therapeutics, Inc. | $7.38 | +5.13% | 158.61 M | -3.28 | -2.25 | 0.00% | Buy | 606 |
| ALXO ALX Oncology Holdings Inc. | $1.90 | +0.53% | 255.67 M | -1.28 | -1.49 | 0.00% | Buy | 582 |
| CAMP CAMP4 Therapeutics Corporation | $4.39 | -2.23% | 93.24 M | -1.87 | -2.35 | 0.00% | Buy | 51 |
| M Macy's, Inc. | $21.76 | -3.07% | 5.74 B | 9.38 | 2.32 | 3.39% | Hold | 4.28 |
| E Eni S.p.A. | $52.16 | -0.29% | 76.82 B | 22.48 | 2.32 | 4.66% | Hold | 367 |
| PMVP PMV Pharmaceuticals, Inc. | $1.20 | +0.84% | 64.00 M | -0.81 | -1.48 | 0.00% | Buy | 408 |
Review BMEA's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
Cash flow statements reveal how BMEA generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether BMEA is outperforming or lagging within its sector.
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether BMEA's profits are repeatable and supported by strong fundamentals.
